Exchange: NASDAQ·Updated 07:49 PM EDT

SION News

News
all
press releases
INVESTIGATION ALERT: Investigation Launched into Sionna Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - SION
INVESTIGATION ALERT: Investigation Launched into Sionna Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - SION INVESTIGATION ALERT: Investigation Launched into Sionna Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP...
PR Newswire
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION PR Newswire NEW YORK, Aug. 27, 2026 NEW YORK, Aug. 27, 2026...
PR Newswire
Robbins LLP Reminds Stockholders it is Investigating the Recent Stock Drop of Sionna Therapeutics
Robbins LLP Reminds Stockholders it is Investigating the Recent Stock Drop of Sionna Therapeutics Robbins LLP Reminds Stockholders it is Investigating the Recent Stock Drop of Sionna Therapeutics PR Newswire SAN DIEGO, Aug. 19, 2026 SAN DIEGO, Aug. 19, 2026 /PRNewswire/ -- Shareholder rights law...
PR Newswire
Sionna Therapeutics (SION) Securities Investigation Notice - Levi & Korsinsky
Sionna Therapeutics (SION) Securities Investigation Notice - Levi & Korsinsky Sionna Therapeutics (SION) Securities Investigation Notice - Levi & Korsinsky PR Newswire NEW YORK, Aug. 19, 2026 Sionna Therapeutics Shares Lost Roughly 90% of Their Value After Phase 2a PreciSION CF Trial of SION-719...
PR Newswire
Investigation Launched into Sionna Therapeutics, Inc. (SION), Robbins Geller Rudman & Dowd LLP Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of United States federal securities laws involving Sionna Therapeutics, Inc. (NASDAQ: SION). If you have information that could assist in the Sionna Therapeutics investigation or if you are a Sionna Therapeutics...
Business Wire
Securities Fraud Investigation IntoSionna Therapeutics, Inc. (SION) Announced Shareholders Who Lost Money Urged To ContactGlancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sionna Therapeutics, Inc. (Sionna or the Company) (NASDAQ: SION) investors concerning the Companys possible violations of the federal securities...
Business Wire
Sionna Therapeutics, Inc. (SION) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Sionna Therapeutics, Inc. (Sionna or the Company) (NASDAQ: SION) investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SIONNA THERAPEUTICS, INC. (SION...
Business Wire
Securities Fraud Investigation Into Sionna Therapeutics, Inc. (SION) Announced Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Sionna Therapeutics, Inc. (Sionna or the Company) (NASDAQ: SION) on behalf of investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON SIONNA THERAPEUTICS, INC. (SION...
Business Wire
Robbins LLP is Investigating the Recent Stock Drop of Sionna Therapeutics; Contact the Firm for Information
Shareholder rights law firm Robbins LLP is investigating Sionna Therapeutics (NASDAQ: SION) to determine whether certain Sionna Therapeutics officers and directors violated securities laws and breached fiduciary duties to shareholders. Why Are We Investigating Sionna Therapeutics? On Monday, August...
Business Wire
SION Investors Have Opportunity to Join Sionna Therapeutics, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sionna Therapeutics, Inc. (Sionna or the Company) (NASDAQ: SION) for violations of the securities laws. INVESTIGATION DETAILS: The investigation...
Business Wire

Advertisement|Remove ads.